Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 29 (NPM1P29) is a processed pseudogene related to the nucleophosmin 1 (NPM1) gene. Pseudogenes like NPM1P29 are typically non-functional remnants of genes that have lost their protein-coding ability. The precise function of NPM1P29 remains unclear, and it is not considered to encode a functional RNA or protein[2]. There is currently no evidence linking NPM1P29 to specific biological functions, disease processes, or therapeutic strategies. The strongest evidence available describes NPM1P29 as a pseudogene with unknown or unclear biological function and no established role as a protein product or drug target[2]. No disease association or therapeutic relevance has been reported in the literature.
None (as it is not a drug target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 29 (NPM1P29).